# Apyx Medical (APYX) Stock Price, News & Analysis
Canonical URL: https://biopharmsignal.com/company/APYX
## Company Profile
- Ticker: APYX
- Exchange: NASDAQ
- Sector: Biopharma
- Location: United States
- Tags: MedTech
## Stock Data
- Close: 3.02 USD
- Market cap: 161214711.35 USD
- Last updated: 2026-08-11
## Business Overview
### Surgical Aesthetics
Apyx Medical develops energy-based systems used in cosmetic and surgical procedures. Its technology is intended to contract soft tissue and support body-contouring outcomes.
### Renuvion
Renuvion combines helium plasma with radiofrequency energy for precise delivery beneath the skin. The platform is used by plastic and cosmetic surgeons in soft-tissue contraction procedures.
### AYON System
AYON is an integrated body-contouring system designed to combine multiple procedural functions in a single platform. Apyx generates revenue from capital equipment, handpieces and other recurring procedure supplies.
## Why The Stock Is Moving

As of Aug 11, 2026, APYX closed down 12.7% at $3.02. No new same-company headline was identified in the current news window.

## Recent News
- 2026-08-06 20:05 EST — [Apyx Medical Corporation Reports Second Quarter 2026 Financial Results](https://biopharmsignal.com/news/APYX/apyx-medical-corporation-reports-second-quarter-2026-financial-results-41096692) — Source: Apyx Medical
- 2026-07-28 12:00 EST — [Apyx Medical Corporation to Participate in the Canaccord Genuity 46th Annual Growth Conference](https://biopharmsignal.com/news/APYX/apyx-medical-corporation-to-participate-in-the-canaccord-genuity-46th-annual-gro-94590452) — Source: Apyx Medical
- 2026-07-23 12:00 EST — [Apyx Medical Corporation to Release Second Quarter of Fiscal Year 2026 Financial Results on August 6, 2026](https://biopharmsignal.com/news/APYX/apyx-medical-corporation-to-release-second-quarter-of-fiscal-year-2026-financial-0275b558) — Source: Apyx Medical
- 2026-05-21 12:00 EST — [New Study Shows Significant Improvement in Cellulite and Skin Laxity with Advanced Minimally Invasive Treatment Utilizing Avéli® and Renuvion®](https://biopharmsignal.com/news/APYX/new-study-shows-significant-improvement-in-cellulite-and-skin-laxity-with-advanc-d19ed0bc) — Source: Apyx Medical
- 2026-05-14 12:00 EST — [Apyx Medical Corporation Announces Retrospective Clinical Publication Evaluating Clinical Benefit of Renuvion® Used in Combination with Liposuction](https://biopharmsignal.com/news/APYX/apyx-medical-corporation-announces-retrospective-clinical-publication-evaluating-065196d3) — Source: Apyx Medical